GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...

Medtronic plc MDT recently announced new data for the Evolut Transcatheter Aortic Valve Replacement System (TAVR) at PCR London Valves 2024. This new clinical data gives implanters treating ...

Medtronic has reported new clinical data from the study of its Evolut transcatheter aortic valve replacement (TAVR) system, which is anticipated to offer fresh insights for global implanters ...

SGMC Health recently achieved the successful completion of its first transcarotid access Transcatheter Aortic Valve ...

Transcatheter aortic valve replacement (TAVR) is valve replacement without open-heart surgery. It is also called catheter-based or percutaneous (through the skin) aortic valve replacement. While ...

THE SOLVE-TAVI trial demonstrated that both valve type and anaesthesia strategy yielded comparable long-term outcomes in transfemoral TAVR, with notable differences in specific clinical measures.

Within Structural Heart, MDT won TAVR (Transcatheter aortic valve replacement) share globally in the fiscal third quarter on the strength of Evolut FX. Specifically, in Europe, Evolut FX generated ...

Risk for bleeding events is significantly affected by DOAC score in patients with atrial fibrillation who have received TAVR.

the CoreValve Evolut TAVR platform has shown consistently low, single-digit gradients and large effective orifice areas that promote valve performance. Aortic stenosis currently affects more than ...

Medtronic plc MDT recently announced new data for the Evolut Transcatheter Aortic Valve Replacement System (TAVR) at PCR London Valves 2024. This new clinical data gives implanters treating patients ...